API
Clarithromycin
Clarithromycin
Modified-Release Tablet
500 mg
Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking peptidyl transferase activity and interfering with amino acid translocation, thereby inhibiting bacterial growth.
Sign in so we can keep your searches with your account for quicker access next time.
Continuing to sign in in 5s
Excel Beyond Limits